Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Enzim-Orbita is a Russian pharmaceutical and nutraceutical company headquartered in Lyubertsy, Moscow region. The company specializes in the development and manufacturing of enzyme-based therapeutic products and dietary supplements, with a strong focus on gastrointestinal health. Their core product offerings include digestive enzyme replacements, such as pancreatin, and various probiotic formulations designed to treat dysbiosis and metabolic disorders. Enzim-Orbita also operates as a contract manufacturing organization (CMO), providing production services for external healthcare brands. The company serves the Russian and Commonwealth of Independent States (CIS) markets, emphasizing the production of high-quality, accessible generic medications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Enzim Orbita.